President, Chief Executive Officer and Director
Erik T. Engelson has served as our President and Chief Executive Officer and as a member of our board of directors since March 2019. Mr. Engelson has also served as a venture partner at ShangBay Capital, a venture capital company, since February 2018. From February 2019 to November 2021, Mr. Engelson was a board member to DeVoro Medical Inc., a therapeutic medical device company.  From August 2018 to July 2022, Mr. Engelson was a board member to Neptune Medical Inc., a therapeutic medical device company.  From April 2016 to February 2019, Mr. Engelson was a board member and consultant to Arrinex, Inc., a therapeutic medical device company. From August 2015 to March 2016, Mr. Engelson was a General Manager at Medtronic PLC, a medical device company.  From August 2014 until its sale to Medtronic PLC in August 2015, Mr. Engelson served as the Chief Executive Officer of Medina Medical, Inc., a medical device company.  Currently, Mr. Engelson is a member of the University of California San Diego Bioengineering Department Board of Trustees, a Trustee of the University of California San Diego Biology Dean’s Leadership Council and a Trustee Emeritus of the UC San Diego Foundation. Mr. Engelson received a B.A. in Microbiology and an M.S. in Bioengineering from University of California, San Diego and an Executive M.B.A. from the Stanford Graduate School of Business.
Chief Financial Officer
Richard Narido previously served as our Vice President of Finance, a role he has held since March 2021. As Chief Financial Officer, Mr. Narido will serve as our principal financial officer and principal accounting officer. From July 2018 to March 2021, Mr. Narido served in various roles at Assembly Biosciences, Inc., including most recently the Executive Director, Finance, and Treasury. From June 2014 to June 2018, Mr. Narido served in various roles at Bio-Rad Laboratories, including Americas Head of Finance, Global Commercial Operations. Prior to that, Mr. Narido held various finance roles, including Global Head Finance Reporting and Accounting for Novartis Vaccines and Diagnostics Division and several positions including business unit Controller for McKesson Corporation. Mr. Narido started his career with PricewaterhouseCoopers’s Financial Audit and Assurance practice. Mr. Narido holds a Bachelor of Science degree from University of San Francisco and a Master of Science degree from Pepperdine Graziadio Business School.
Chief Operations Officer

Tony Allen has served as our Chief Operations Officer since September 2021. From May 2018 to September 2021, Mr. Allen served as Vice President and Head of Global Internal Manufacturing at Ortho-Clinical Diagnostics, Inc., an in vitro diagnostics company. Mr. Allen served as Vice President and General Manager at Gap Partners, Inc., a metal fabrication company, from March 2017 to May 2018, Global Senior Project Management Office Head at Alcon Inc., an eye care device company, from March 2016 to March 2017 and Vice President of Operations at Accriva Diagnostics Holdings, Inc., a medical equipment and supplies manufacturing company, from October 2015 to March 2016. Prior to that he served in various operations and leadership roles at DJO Global, Inc., an orthopedic medical device company, for approximately eight years and at NEC Computers International, an information technology and electronics company, for approximately nine years. Mr. Allen received a T5 in telecommunications and radio communications from the Department of Marine Radio and Radar, Limerick, Ireland and an Executive M.B.A. from Aberdeen University.

Chief Revenue Officer

Kevin Collins has served as our Chief Revenue Officer Since May 2021. Mr. Collins has over 15 years of commercial leadership experience in the medical technology industry. Prior to Joining Lucira, Mr. Collins served as Vice President of International Commercial Operations and Head of Sales and Market Development at Outset Medical. Prior to joining Outset, Kevin spent 12 years at Intuitive Surgical where he served as the Vice President for the Global Distribution business unit. Mr. Collins earned a B.A. in Communications and Political Science from the University of Arizona.

Chief Quality Officer and Executive Vice President Regulatory Affairs

Ghazi Kashmolah has served as our Chief Quality Officer and Executive Vice President Regulatory Affairs since August 2021. Mr. Kashmolah has more than 30 years of experience in quality and regulatory work leading, developing and transforming global quality in the medical device and biotech industries. Most recently, he was Chief Quality Assurance, Regulatory Affairs, and EH&S Officer at Orchid Orthopedic Solutions. Prior to that, he led quality and regulatory affairs as SVP of QA/RA for DJO Global, VP of QA/RA at OSI Systems, and VP of Global QA/RA at Life Technologies. At Cardinal Health, Mr. Kashmolah was VP, Global Operations including manufacturing, supply chain, and quality. Mr. Kashmolah holds BS in electrical engineering from Wayne State University, an MS degree in electrical engineering from West Coast University, as well as an Executive MBA from University of Iowa Tippie School of Management.

Chief Human Resources Officer
Nadine Greiner, Ph.D. has served as our Chief Human Resources Officer since June, 2022.  Nadine's career has consisted of leading organizations through rapid growth and change.  She has led the Human Resources function at private and public companies, and for capital ventures as well as for companies of over 15B in revenue. She has served as the head of Human Resources at the following: 4D Molecular Therapeutics, Sutter Health (California Pacific Medical Center and Palo Alto Medical Foundation), The Institute on Aging, Brown and Toland, Uplift Family Services, and globally in the Corporate Groups at Bank of America.  
Nadine earned a dual doctorate in Organization Development and Clinical Psychology.